Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Tag: EULAR2025

EULAR 2025 highlights…

EULAR 2025 Highlights – Imaging

18 Jul 202518 Jul 2025
⁶⁸Ga-FAPI-04 PET/CT as a Novel Assessment Tool for Systemic Sclerosis: Linking Imaging Findings to Clinical Features of Lung and Skin-Muscle Disease Abstract format and assignment number: Poster 0624 Presenting author:…
EULAR 2025 highlights…

EULAR 2025 Highlights – Metabolic and Crystal arthropathies

18 Jul 2025
Genakumab reduces the risk of acute gout flares during initiation of urate-lowering therapy: A phase 2, randomized, open-label, multi-center, active-controlled clinical trial Abstract format and assignment number: Oral presentation OP0299…

Posts navigation

Newer posts

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...